Envista Holdings Corporation (NYSE:NVST) Receives Average Rating of “Hold” from Analysts

Envista Holdings Corporation (NYSE:NVST) has been given a consensus recommendation of “Hold” by the sixteen ratings firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $21.7692.

NVST has been the topic of several analyst reports. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 15th. Robert W. Baird set a $27.00 price target on shares of Envista in a report on Friday, October 31st. Stifel Nicolaus set a $25.00 price objective on shares of Envista in a research note on Thursday, October 30th. Evercore ISI reiterated an “outperform” rating on shares of Envista in a report on Friday, October 31st. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th.

Hedge Funds Weigh In On Envista

Hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC lifted its position in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after purchasing an additional 638 shares during the last quarter. Claret Asset Management Corp increased its stake in Envista by 6.5% in the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock worth $231,000 after buying an additional 724 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Envista by 35.3% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,041 shares of the company’s stock valued at $62,000 after buying an additional 793 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC boosted its position in Envista by 5.6% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 20,100 shares of the company’s stock valued at $393,000 after buying an additional 1,067 shares during the period.

Envista Trading Up 3.0%

NYSE NVST opened at $23.61 on Friday. The firm has a market cap of $3.88 billion, a PE ratio of 262.36, a price-to-earnings-growth ratio of 1.02 and a beta of 0.99. Envista has a 1-year low of $14.22 and a 1-year high of $23.71. The stock has a 50-day moving average of $20.99 and a 200-day moving average of $20.58. The company has a current ratio of 2.37, a quick ratio of 2.02 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Envista had a return on equity of 5.90% and a net margin of 0.58%.The business had revenue of $669.90 million for the quarter, compared to analysts’ expectations of $639.49 million. During the same period in the previous year, the firm earned $0.12 EPS. The business’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, sell-side analysts forecast that Envista will post 1 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.